The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Ta - so I have 975 @ $3.00 or thereabouts.
More would be nice.
I'm not sure OTC price will be truly representative though, will it?
Thankz :-)
So I've got 19k Accustem shares, is it only 1.9k when they finally list?
Unfortunately I'm finding that that is the standard of most call centres and support lines these days. Especially if your scenario isn't in their script. Have you ever dealt with Virgin Media or o2 for instance?
Must admit I think that reply is reasonable.
It must be a very unusual, if not unique, situation that we are all in, including our providers, and there has been, and remains, ample scope for confusion. The company is more to blame than your provider IMO, for sheer lack of info and clarity.
Given Accustem aren't yet properly listed (unless I missed something!!) that statement seems reasonable!!
Same here Nelson, don't understand the detail but the sentiment looks good.
I have quite a few of these shares so once (if) they ever become tradeable this might just give them some value.
I am definitely NOT giving advice, just my own view, but if I hadn't suffered a major blow on Synairgen, and if these shares were more readily available, I might have thought about dropping a very modest amount in for a real gamble on the back of this, as they are so cheap.
I'm adding this to this thread before the other thread gets lost - Rockz found a peer review of StemPrinter which looks pretty favourable.
https://www.sciencedirect.com/science/article/pii/S0959804922000077
I've no idea how that might translate into money really. I remember guesstimates at the time were fairly substantial but I'm not holding my breath.
Isn't the entire premise of MrCosts posts negated by the date error?
Not least when he summarises that "Report was published on 25.05.20 which takes us to 25.05.21 for 12 months cash flow therefore in less than 100 days by the company's own admission we could stop operational existence.". That date being last year sometime...
I'd be asking the mods to delete it if it were me :-)
From memory Tils gave Accustem £3m working fund to keep them going while they progressed the project. I don't recall anything about apportionment of cost. Was that in the RNS.
There will be a "rush to market" when they realise they need to do a raise because the £3m has been spent and they want more from us poor suckers!!!
I'm surprised that the company has got away with it.
They have some history of being more than a little disruptive when they don't think the company they are invested in is heading the right way, or a T/O offer is inadequate. They are good for us I believe, as they have he same objectives.
tbh I'm not reading much into the Closing Dates on the vacancies as they don't appear in Synairgen's own ads or, from memory, the original ones which i thought were Ashfield. The jobs can be found on a number of other recruitment sites and I suspect they just steal the ads and try to refer candidates for a %age, like regularly happens here in the UK (I know from experience). Maybe their software demands a Closing Date so it is an arbitrary one.
You can find the role advertised on a few sites, without closing dates. E.G. https://tinyurl.com/mr2huv93
But then - it may be filled. I'm just not sure that an expired closing date on an aggregator site is a reliable indicator.